Latest Research And Development News

DroneShield Limited has delivered a blockbuster quarter with record revenue and operating cash flow, driven by new SaaS products and major government contracts. The company is positioning itself for sustained profitability and expansion into civilian markets.

Vectus Biosystems has had its ASX trading suspension lifted following the disclosure of a significant transaction involving a compound from its drug library, signaling renewed investor interest.

Talga Group has won a SEK 82.6 million (A$13.3 million) grant from the Swedish Energy Agency to advance its low-emission graphite anode project, accelerating its path to commercial-scale production in Sweden.

Swift Networks has expanded its partnership with Uniting NSW to 25 aged care sites and introduced Swift TV at a major industry conference, positioning itself at the forefront of aged care technology innovation.

IMDEX Limited reported a resilient FY25 with steady margins, reduced net debt, and strategic acquisitions positioning it for growth. The company’s FY26 outlook is optimistic, supported by improving global exploration activity and technology adoption.

Alma Metals is advancing its Briggs Copper Project with a deep diamond drill hole underway and the scoping study nearing completion, supported by a Queensland Government grant and solid financial footing.

Hazer Group has received a $4.58 million R&D tax incentive refund for FY25, reinforcing its financial position as it advances its methane pyrolysis technology towards commercialisation.

Cogstate Limited reports a record-breaking quarter with sales contracts soaring 88% year-on-year, driven by expanding markets and new therapeutic areas. The company signals continued investment in growth initiatives, including AI and Asia-Pacific expansion, while projecting a strong first half of FY26.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

Metallium Limited announces a breakthrough rare earth recovery method using Flash Joule Heating with chlorination, promising faster, cleaner recycling of critical metals from magnet waste and advancing U.S. supply chain independence.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.